An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. The drug dupilumab (Dupixent) effectively clears up airways plugged by mucus during an asthma attack, researchers reported Oct. 27 in the American Journal of Respiratory and Critical Care Medicine. Results found half as many patients had… read on > read on >



















